Sep 15, 2009
111th Congress, 2009–2010
Enacted — Signed by the President on Oct 5, 2010
This bill was enacted after being signed by the President on October 5, 2010.
Senator from Oregon
Read Text »
Last Updated: Sep 24, 2010
Length: 3 pages
About the bill
A bill to provide for an exclusion under the Supplemental Security Income program and the Medicaid program for compensation provided to individuals who participate in clinical trials for rare diseases or conditions.
This is the first step in the legislative process.
The bill was passed in a vote in the Senate. It goes to the House next. The vote was by Unanimous Consent so no record of individual votes was made.
The bill was passed by both chambers in identical form. It goes to the President next who may sign or veto the bill. The vote was by voice vote so no record of individual votes was made.
Enacted — Signed by the President
The President signed the bill and it became law.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2016). S. 1674 — 111th Congress: Improving Access to Clinical Trials Act of 2009. Retrieved from https://www.govtrack.us/congress/bills/111/s1674
“S. 1674 — 111th Congress: Improving Access to Clinical Trials Act of 2009.” www.GovTrack.us. 2009. August 24, 2016 <https://www.govtrack.us/congress/bills/111/s1674>
|title=S. 1674 (111th)
|accessdate=August 24, 2016
|author=111th Congress (2009)
|date=September 15, 2009
|quote=Improving Access to Clinical Trials Act of 2009